You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

torasemide immediate release

Showing 1 - 25 of 9,451
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial (ABBV-903)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Oct 5, 2023

Healthy Participants Trial in Ruddington (ALXN2050 MR Prototype Tablet, ALXN2050 Immediate Release (IR) Tablet, ALXN2050 MR

Not yet recruiting
  • Healthy Participants
  • ALXN2050 MR Prototype Tablet
  • +2 more
  • Ruddington, Nottinghamshire, United Kingdom
    Quotient Science Ltd
Mar 13, 2023

Healthy Volunteers Trial (BMS-986419 DR Capsule, BMS-986419 IR Tablet)

Not yet recruiting
  • Healthy Volunteers
  • BMS-986419 DR Capsule
  • BMS-986419 IR Tablet
  • (no location specified)
Jul 20, 2023

Atopic Dermatitis Trial in Hangzhou (TLL-018 extended-release tablet, TLL-018 immediate-release tablet)

Active, not recruiting
  • Atopic Dermatitis
  • TLL-018 extended-release tablet
  • TLL-018 immediate-release tablet
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital Zhejiang University School of Med
Jul 12, 2023

Flat Foot Trial in Istanbul (Graston, Percussive massage)

Completed
  • Flat Foot
  • Graston
  • Percussive massage
  • Istanbul, Turkey
    İstanbul Gelisim University
Sep 14, 2023

Healthy Trial in Porto (Dynamic foam rolling)

Recruiting
  • Healthy
  • Dynamic foam rolling
  • Porto, Portugal
  • +1 more
Feb 10, 2023

Tension-Type Headache Trial in Rawalpindi (sustained natural apophyseal glides (SNAGS), suboccipital muscle release,

Active, not recruiting
  • Tension-Type Headache
  • sustained natural apophyseal glides (SNAGS)
  • +2 more
  • Rawalpindi, Punjab, Pakistan
    Fauji Foundation Hospital
May 22, 2023

N/A Healthy Individuals Trial (Myofascial Release, Light Touch Contact)

Not yet recruiting
  • N/A Healthy Individuals
  • Myofascial Release
  • Light Touch Contact
  • (no location specified)
Jun 21, 2023

Healthy Participants Trial in Overland Park (Treatment A: Emraclidine 30mg IR tablets (reference), Treatment B: Emraclidine 30mg

Not yet recruiting
  • Healthy Participants
  • Treatment A: Emraclidine 30mg IR tablets (reference)
  • +3 more
  • Overland Park, Kansas
    Overland Park, Kansas
Jun 28, 2023

Neuropathic Pain, Diabetes, Type 2 Trial in Korea, Republic of (pregabalin sustained release tablet, pregabalin immediate

Active, not recruiting
  • Neuropathic Pain
  • Diabetes Mellitus, Type 2
  • pregabalin sustained release tablet
  • pregabalin immediate release capsule
  • Cheongju, Chungcheongbuk-do, Korea, Republic of
  • +7 more
Nov 14, 2022

Myofascial Spasm Trial in Istanbul (Self myofascial Release, myofascial release)

Not yet recruiting
  • Myofascial Spasm
  • Self myofascial Release
  • myofascial release
  • Istanbul, Maltepe, Turkey
  • +2 more
Apr 6, 2023

Hamstring Injury, Masseter, Myofascial Release Trial in Ankara (Static stretching, Myofascial Release)

Recruiting
  • Hamstring Injury
  • +5 more
  • Static stretching
  • Myofascial Release
  • Ankara, Keçiören, Turkey
    Caglar Soylu
Jan 26, 2023

Healthy Volunteer Trial in Grayslake (ABBV-903 Tablet Form 1, ABBV-903 Tablet Form 2)

Recruiting
  • Healthy Volunteer
  • ABBV-903 Tablet Form 1
  • ABBV-903 Tablet Form 2
  • Grayslake, Illinois
    Acpru /Id# 254926
Apr 20, 2023

Healthy Trial (Dexamethasone, Chronocort: fasted, Immediate release hydrocortisone: fasted)

Completed
Has Results
  • Healthy
  • (no location specified)
Apr 5, 2022

Lateral Epicondylitis Trial in Lahore (mulligan mobilization, myofascial release)

Completed
  • Lateral Epicondylitis
  • mulligan mobilization
  • myofascial release
  • Lahore, Punjab, Pakistan
    Sumra Riaz
Oct 1, 2022

Recreational Drug Use Trial in Columbus (PF614, Oxycodone, Placebo)

Completed
  • Recreational Drug Use
  • Columbus, Ohio
    Ohio Clinical Trails
Dec 23, 2022

Chronic Rhinosinusitis (Diagnosis) Trial (Budesonide, Mucosal Atomization Device, NeilMed squeeze bottle for Impregnated Nasal

Withdrawn
  • Chronic Rhinosinusitis (Diagnosis)
  • (no location specified)
Jul 7, 2022

Abuse Potential Trial in Overland Park (Placebo, Alprazolam 2 mg, Gabapentin Enacarbil Immediate Release (GE-IR) 200 mg)

Completed
  • Abuse Potential
  • Placebo
  • +4 more
  • Overland Park, Kansas
    Altasciences Clinical Kansas
Oct 19, 2023

Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending

Not yet recruiting
  • Bladder Cancer
  • APL-1202 and APL-1501 (Single ascending dose)
  • APL-1202 and APL-1501 (Multiple Ascending dose)
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Sep 11, 2023

Recreational Drug Use Trial in Overland Park (PF614, Oxycodone Hydrochloride 40 mg, Placebo)

Completed
  • Recreational Drug Use
  • Overland Park, Kansas
    Dr. Vince Clinical Research
Jan 3, 2023

Hyperactivity in Children With Down Syndrome, Impulsivity in Children With Down Syndrome Trial (Guanfacine Hydrochloride

Not yet recruiting
  • Hyperactivity in Children With Down Syndrome
  • Impulsivity in Children With Down Syndrome
  • Guanfacine Hydrochloride Immediate Release
  • Placebo
  • (no location specified)
Sep 18, 2023

Healthy Trial in Nottingham (BLU-5937 IR, BLU-5937 ER)

Recruiting
  • Healthy
  • BLU-5937 IR
  • BLU-5937 ER
  • Nottingham, England, United Kingdom
    Quotient Sciences
Oct 4, 2022

Safety Issues, Pharmacokinetic Trial in Kiel (controlled-ileocolonic-release nicotinamide (SAD/MAD/MD), Immediate-release

Recruiting
  • Safety Issues
  • Pharmacokinetic
  • controlled-ileocolonic-release nicotinamide (SAD/MAD/MD)
  • +3 more
  • Kiel, Germany
    University Medical Center Schleswig-Holstein
Feb 16, 2022

Bioequivalence Trial in Lenexa (Pharmaceutical-lipid aspirin (PL-ASA))

Completed
  • Bioequivalence
  • Pharmaceutical-lipid aspirin (PL-ASA)
  • Lenexa, Kansas
    PRA-EDS
Apr 20, 2022

Kidney Transplant Rejection Trial in Los Angeles (Extended-release tacrolimus, Immediate-release tacrolimus)

Recruiting
  • Kidney Transplant Rejection
  • Extended-release tacrolimus
  • Immediate-release tacrolimus
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jan 18, 2022